As of November 2024, Anavex Life Sciences has a market cap of $440.43M. This makes Anavex Life Sciences the world's 12000th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $462.77M | -37.70% |
2023 | $742.82M | 0.54% |
2022 | $738.83M | -46.60% |
2021 | $1.38B | 221.11% |
2020 | $430.85M | 108.49% |
2019 | $206.65M | 66.03% |
2018 | $124.47M | -51.55% |
2017 | $256.92M | -18.69% |
2016 | $315.96M | -28.90% |
2015 | $444.42M | 652.70% |
2014 | $59.04M | -26.00% |
2013 | $79.79M | -68.35% |
2012 | $252.13M | -35.25% |
2011 | $389.36M | -66.58% |
2010 | $1.16B | 69.77% |
2009 | $686.17M | -17.31% |
2008 | $829.79M | -50.48% |
2007 | $1.68B | 94.44% |
2006 | $861.71M | - |